Advertisement

Pediatric Surgery International

, Volume 19, Issue 7, pp 509–519 | Cite as

The epidemiology of neonatal tumours

Report of an international working group
  • S. W. MooreEmail author
  • D. Satgé
  • A. J. Sasco
  • A. Zimmermann
  • J. Plaschkes
Review Article

Abstract

Neonatal tumours occur every 12,500–27,500 live births and comprise 2% of childhood malignancies, but there is little clarity as to their real prevalence, sites of origin and pathological nature as reported series vary. As an entity, neonatal tumours provide a unique window of opportunity to study tumours in which minimal environmental interference has occurred. The majority of tumours present with a mass at birth (e.g., teratomas, neuroblastomas, mesoblastic nephroma, fibromatosis), which are not infrequently identified on antenatal ultrasound. Histologically, teratoma and neuroblastoma remain the two main tumour types encountered with soft tissue sarcoma, renal tumours, CNS tumours and leukaemia being the next most common tumour types identified. Malignant tumours are uncommon in the neonatal period per se and benign tumours may have malignant potential. A particular problem exists in clinical classification, as histological features of malignancy do not always correlate with clinical behaviour. Benign tumours may also be life threatening because of their size and location. Other tumours may demonstrate local invasiveness, but no metastatic potential, and tumours that are clearly malignant may demonstrate unpredictable or uncertain behaviour. Screening programmes have brought more tumours to light, but do not appear to affect the overall prognosis. They may provide clues to the stage at which tumours develop in foetu. The aetiology of cancer in children is multifactorial and includes both genetic and environmental factors. The association between congenital abnormalities and tumours is well established (15% of neonatal tumours). Genetic defects are highly likely in neonatal tumours and include those with a high risk of malignancy (e.g., retinoblastoma), but also genetically determined syndromes with an increased risk of malignancy and complex genetic rearrangements. Tumours are mostly genetically related at a cellular level and factors influencing cellular maturation or apoptosis within the developing foetus may continue to operate in the neonatal period. Cytogenetics of neonatal neoplasms appear to differ from neoplasms in older children, thus possibly explaining some of the observed differences in clinical behaviour. Certain constitutional chromosome anomalies, however, specifically favour tumuors occurring in the foetal and neonatal period. In support of this hypothesis, certain cytogenetic anomalies appear to be specific to neonates, and a number of examples are explored. Other environmental associations include ionizing radiation, drugs taken during pregnancy, infections, tumours in the mother and environmental exposure.

Keywords

Neonatal tumours Congenital tumours Neonate Children 

References

  1. 1.
    Acharya S, Jayabose S, Kogan SJ, Tugal O, Beneck D, Leslie D, Slim M (1997) Prenatally diagnosed neuroblastoma. Cancer 80:304–310CrossRefPubMedGoogle Scholar
  2. 2.
    Adelstein AM, Donovan JW (1972) Malignant disease in children whose mothers had chickenpox, mumps, or rubella in pregnancy. Brit Med J 4:629–631Google Scholar
  3. 3.
    Al-Sheyyab M, Muir KR, Cameron AH, Raafat F, Pincott JR, Parkes SE, Mann JR (1993) Malignant epithelial tumours in children: incidence and aetiology. Med Pediatr Oncol 21:421–428PubMedGoogle Scholar
  4. 4.
    Altmann AE, Halliday JL, Giles GG (1998) Associations between congenital malformations and childhood cancer: a register-based case-control study. Br J Cancer 78:1244–1249PubMedGoogle Scholar
  5. 5.
    Ammann RA, Plaschkes J, Leibundgut K (1999) Congenital hepatoblastoma: a distinct entity? Med Pediatr Oncol 32:466–468PubMedGoogle Scholar
  6. 6.
    Andersen DH (1951) Tumours of infancy and childhood. Cancer 4:890–906Google Scholar
  7. 7.
    Aydingöz U, Emir S, Karli-Oguz K, Köse G, Büyükpamukçu M (2002) Congenital infiltrating lipomatosis of the face with ipsilateral hemimegalencephaly. Pediatr Radiol 32:106–109CrossRefPubMedGoogle Scholar
  8. 8.
    Azizkhan RC (1999) Neonatal tumours. In: Carachi R, Azmy A, Grosfeld JL (eds) The surgery of childhood tumours. Arnold, London. pp 107–123Google Scholar
  9. 9.
    Bader JL, Miller RW (1979) US Cancer incidence and mortality in the 1st year of life. Am J Dis Child 133:157–159PubMedGoogle Scholar
  10. 10.
    Barson AJ (1978) Congenital neoplasia: The Society's experience. Arch Dis Child 53:436Google Scholar
  11. 11.
    Batcup G (1992) Cancer in the very young child—pitfalls and problems for the pathologist. Br J Cancer 66 [Suppl XVIII]:S5-S7Google Scholar
  12. 12.
    Beckwith J, Perrin E (1963) In situ neuroblastomas: a contribution to the natural history of neural crest tumours. Am J Pathol 43:1089–1104Google Scholar
  13. 13.
    Bergeron C, Frappaz D, Combaret V, Thiesse Ph, Ranchere-Vince D, Mathieu P, Greffe J, Favrot M, Chauvin F, Chappiuis JP, David L, Philip T (1998) Neuroblastoma screening in France: Clinical, biological features and evolution of neuroblastomas from the cohort (1990–1994). Med Pediatr Oncol 31:268CrossRefGoogle Scholar
  14. 14.
    Birch JM, Marsden HB, Swindell R (1982) Pre-natal factors in the origin of germ cell tumours of childhood. Carcinogenesis 3:75–80PubMedGoogle Scholar
  15. 15.
    Birch JM, Blair V (1992) The epidemiology of infant cancers. Br J Cancer 66 [Suppl XVIII]:S52-S54Google Scholar
  16. 16.
    Blank E, Neerhout RC, Burry KA (1978) Congenital mesoblastic nephroma and polyhydramnios. JAMA 240:1504–1505CrossRefPubMedGoogle Scholar
  17. 17.
    Boffetta P, Tredaniel J, Greco A (2000) Risk of childhood cancer and adult lung cancer after childhood exposure to passive smoke: a meta-analysis. Environ Health Perspect 108:73–82PubMedGoogle Scholar
  18. 18.
    Borch K, Jacobsen T, Olsen JH, Hirsch F, Hertz H (1992) Neonatal cancer in Denmark 1943–1985. Ugeskr Laeger 10 156:176–179Google Scholar
  19. 19.
    Bourgeois JM, Knezevich SR, Mathers JA, Sorensen PHB (2000) Molecular detection of the ETV6-NTRK3 gene fusion differentiates congenital fibrosarcoma from other childhood spindle cell tumours. Am J Surg Pathol 24:937–946CrossRefPubMedGoogle Scholar
  20. 20.
    Bresters D, Reus ACW, Veerman AJP, van Wering ER, van der Does-van den Berg A, Kaspers GJL (2002) Congenital leukaemia: the Dutch experience and review of the literature. Br J Haematol 117:513–524CrossRefPubMedGoogle Scholar
  21. 21.
    Brinkschmidt C, Poremba C, Christiansen H, Simon R, Schafer KL, Terpe HJ, Lampert F, Boecker W, Dockhorn-Dworniczak B (1998) Compararive genomic hybridization and telomerase activity analysis identify two biologically different groups of 4S neuroblastomas. Br J Cancer 77:2223–2229PubMedGoogle Scholar
  22. 22.
    Broadbent VA (1986) Malignant disease in the neonate. In: Robertson N (ed) Textbook of neonatology. Churchill Livingstone, Edinburgh pp 689–695Google Scholar
  23. 23.
    Brodeur GM, Castleberry RP (1997) Neuroblastoma. In: Pizzo PA, Poplack DG (eds) Principles and practice of pediatric oncology. JB Lippincott, Philadelphia, pp 761–797Google Scholar
  24. 24.
    Brodeur GM, Seeger RC, Schwab M, Varmus HE, Bishop JM (1984) Amplification of N-myc in untreated human neuroblastomas correlates with advanced disease stage. Science 224:1121–1124Google Scholar
  25. 25.
    Brodeur GM, Look AT, Shimada H, Hamilton VM, Maris JM, Hann HW, Leclerc JM, Bernstein M, Brisson LC, Brossard J, Lemieux B, Tuchman M, Woods WG (2001) Biological aspects of neuroblastomas identified by mass screening in Quebec. Med Pediatr Oncol 36:157–159CrossRefPubMedGoogle Scholar
  26. 26.
    Bruisma F, Venn A, Lancaster P, Speirs A, Healy D (2000) Incidence of cancer in children born after in vitro fertilization. Hum Reprod 15:604–607CrossRefPubMedGoogle Scholar
  27. 27.
    Buckley JD (1992) The aetiology of cancer in the very young. Br J Cancer [Suppl XVIII]:S8–S12Google Scholar
  28. 28.
    Call KM, Glaser T, Ito CY, Buckler AJ, Pelletier J, Haber DA, Rose EA, Kral A, Yeger H, Lewis WH, Jones C, Houseman D (1990) Isolation and characterization of a zinc finger polypeptide gene at the human chromosome 11 Wilms' tumour locus. Cell 60:509–520PubMedGoogle Scholar
  29. 29.
    Campbell AN, Chan HSL, O'Brien A, Smith CR, Becker LE (1987) Malignant tumours in the neonate. Arch Dis Child 62:19–23PubMedGoogle Scholar
  30. 30.
    Capelli A, Familiari U, Fundaro C, Segni G, Carbone A, Larocca LM (1989) CNS lymphoma in a newborn infant with HIV-1 infection. Path Res Pract 185:A29Google Scholar
  31. 31.
    Cavanee WK, Dryja TP, Phillips RA, Benedict WF, Godbout R, Gallie BL, Murphree AL, Strong LC, White RL (1983) Expression of recessive alleles by chromosomal mechanisms in retinoblastoma Nature 305:779–784Google Scholar
  32. 32.
    Chadduck WM, Gollin SM, Gray BA, Norris JS, Araoz CA, Tryka AF (1987) Gliosarcoma with chromosome abnormalities in a neonate exposed to heptachlor. Neurosurgery 21:557–559PubMedGoogle Scholar
  33. 33.
    Chakova L, Stoyanova A (1996) Solid tumours in newborns and infants. Folia Med (Bulgaria) 38:39–43Google Scholar
  34. 34.
    Comings DE (1973) A general theory of carcinogenesis. Proc Natl Acad Sci USA 70:3324–3328PubMedGoogle Scholar
  35. 35.
    Coppes MJ, Campbell CE, Williams BR (1993) The role of WT1 in Wilms tumourigenesis. FASEB J 7:886–895PubMedGoogle Scholar
  36. 36.
    Crom DB, Wilimas JA, Green AA, Pratt CB, Jenkins JJ, Behm FG (1989) Malignancy in the neonate. Med Pediatr Oncol 17:101–104PubMedGoogle Scholar
  37. 37.
    Davis CF, Carachi R, Young DG (1988) Neonatal tumours: Glasgow 1955–1986. Arch Dis Child 63:1075–1078PubMedGoogle Scholar
  38. 38.
    Denys P, Malvaux P, Van den Berghe H, Tanghe W, Proesmans W (1967) Association d'un syndrome anatomo-pathologique de pseudohermaphrodisme masculin, d'une tumeur de Wilms, d'une néphropathie parenchymateuse et d'un mosaïcisme XX/XY. Arch Fr Pediatr 24:729–739PubMedGoogle Scholar
  39. 39.
    Doll R, Wakeford R (1997) Risks of childhood cancer from fetal irradiation. Br J Radiol 70:130–139PubMedGoogle Scholar
  40. 40.
    Drash A, Sherman F, Hartmann WH, Blizzard RM (1970) A syndrome of pseudohermaphroditism, Wilms' tumour, hypertension and degenerative renal disease. J Pediatr 76:585–593PubMedGoogle Scholar
  41. 41.
    Eggert A, Grotzer MA, Zuzak TJ, Wiewrodt BR, Ikegaki N, Brodeur GM (2000) Resistance to TRAIL-induced apoptosis in neuroblastoma cells correlates with a loss of caspase-8 expression. Med Pediatr Oncol 35:603–607CrossRefPubMedGoogle Scholar
  42. 42.
    Fedrick J, Alberman ED (1972) Reported influenza in pregnancy and subsequent cancer in the child. Br Med J 2:485–488PubMedGoogle Scholar
  43. 43.
    Feusner J, Plaschkes J (2002) Hepatoblastoma and low birth weight: a trend or chance observation? Med Pediatr Oncol 39:508–509CrossRefPubMedGoogle Scholar
  44. 44.
    Fraumeni JF, Miller RW (1969) Cancer deaths in the newborn. Am J Dis Child 117:186–189PubMedGoogle Scholar
  45. 45.
    Gale GB, D'Angio GJ, Uri A, Chatten J, Koop CE (1982) Cancer in the neonate: the experience at the children's hospital of Philadelphia. Pediatrics 70:409–413PubMedGoogle Scholar
  46. 46.
    Girschick HJ, Klein R, Scheurlen WG, Kühl J (2001) Cytogenetic and histopathologic studies of congenital supratentorial primitive neuroectodermal tumours: a case report. Pathol Oncol Res 7:67–71PubMedGoogle Scholar
  47. 47.
    Goh KO, Lee H, Klemperer M (1980) Evidence of clastogens in acute leukaemia. Chromosomal abnormalities in healthy parents of congenital leukemic patients. Cancer 46:109–117PubMedGoogle Scholar
  48. 48.
    Greenberg RS, Daniels SR, Flanders WD Eley JW, Boring JR III (eds) (1996) Epidemiological studies of genetics in Medical Epidemiology, 3rd edn. Lange, New York, pp 153–163Google Scholar
  49. 49.
    Grundy R, Anderson J, Gaze M, Gerrard M, Glaser A, Gordon A, Malone M, Pritchard-Jones K, Michalski A (2001) Congenital alveolar rhabdomyosarcoma: clinical and molecular distinction from alveolar rhabdomyosarcoma in older children. Cancer 91:606–612CrossRefPubMedGoogle Scholar
  50. 50.
    Gutierrez-Ortega P, Hierro-Orozco S, Sanchez-Cisneros R, Montano LF (1989) Kaposi's sarcoma in a 6-day-old infant with human immunodeficiency virus. Arch Dermatol 125:432–433CrossRefPubMedGoogle Scholar
  51. 51.
    Gurney JG, Severson RK, Davis S, Robison LL (1995) Incidence of cancer in children in the United States: sex-race-and 1-year age-specific rates by histological type. Cancer 75:2186–2195PubMedGoogle Scholar
  52. 52.
    Hachitanda Y, Ishimoto K, Hata J, Shimada H (1994) One hundred neuroblastomas detected through a mass screening system in Japan. Cancer 74:3223–3226PubMedGoogle Scholar
  53. 53.
    Hadley GP,Govender D, Landers G (2002) Malignant solid tumours in neonates: an African perspective Pediatr Surg Int 18:653–657Google Scholar
  54. 54.
    Halperin EC (2000) Neonatal neoplasms. Int J Radiat Oncol Biol Phys 47:171–178PubMedGoogle Scholar
  55. 55.
    Hisaoka M, Sheng WQ, Tanaka A, Hashimoto H (2002) Gene expression of TrkC (NTRK3) in human soft tissue tumours. J Pathol 197:661–667CrossRefPubMedGoogle Scholar
  56. 56.
    Holland WW, Doll R, Carter CO (1962) The mortality from leukaemia and other cancers among patients with Down's syndrome (Mongols) and among their parents. Brit J Cancer 16:177–186Google Scholar
  57. 57.
    Iehara T, Hamazaki M, Sawada T (2002) Cytogenetic analysis of infantile neuroblastomas by comparative genomic hybridization. Cancer Lett 178:83–89CrossRefPubMedGoogle Scholar
  58. 58.
    Isaacs H (1985) Perinatal (congenital and neonatal) neoplasms: a report of 110 cases Pediatr Pathol 3:165–216Google Scholar
  59. 59.
    Jaffe N (1976) Late side effects of treatment: skeletal, genetic, central nervous system and oncogenic. Pediatr Clin North Am 23:233–244PubMedGoogle Scholar
  60. 60.
    Jaing TH, Hung IJ, Lin JN, Lien RI, Hsueh C, Lu CS (2002) Hepatoblastoma in a child of extremely low birth-weight. Am J Perinatol 19:149–153CrossRefPubMedGoogle Scholar
  61. 61.
    Jennings RW, la Quaglia MP, Leong K, Harvey Hendron W, Scott-Adzick N (1993) Fetal neuroblastomas: prenatal diagnosis and natural history. J Pediatr Surg 28:1168–1174PubMedGoogle Scholar
  62. 62.
    Ji BT, Shu XO, Linet MS, Zheng W, Wacholder S, Gao YT, Ying DM, Jin F (1997) Paternal cigarette smoking and the risk of childhood cancer among offspring of non-smoking mothers. J Natl Cancer Inst 89:238–244CrossRefPubMedGoogle Scholar
  63. 63.
    Kerbl R, Urban CE, Ladenstein R, Lackner H, Schwinger W, Fauler G, Ambros IM, Ambros PF (1998) Neuroblastoma screening after the 6th month of age may be of more benefit than screening in early infancy. Med Pediatr Oncol 31:285CrossRefGoogle Scholar
  64. 64.
    Knudson AG Jr (1971) Mutation and cancer: statistical study of retinoblastoma. Proc Natl Acad Sci USA 68:820–823PubMedGoogle Scholar
  65. 65.
    Knudson AG Jr, Strong LC (1972) Mutation and cancer: a model for Wilms' tumour of the kidney. J Natl Cancer Inst 48:313–324PubMedGoogle Scholar
  66. 66.
    Koren G (1996) Intra-uterine causes of tumours in later life. In: Koren G, Lishner M, Farine D (eds) Cancer in pregnancy. Maternal and fetal risks. Cambridge University Press, Cambridge, pp 189–204Google Scholar
  67. 67.
    Las Heras J, Isaacs H (1987) Congenital tumours. Birth Defects 23:421–431Google Scholar
  68. 68.
    Lichtenstein P, Holm N, Verkasalo PK, Iliadou A, Kaprio J, Koskenvuo M, Pukkala E, Skytthe A, Hemminki K (2000) Environmental and heritable factors in the causation of cancer-analyses of cohorts of twins from Sweden, Denmark and Finland. N Eng J Med 343:78–85CrossRefGoogle Scholar
  69. 69.
    Little J (1999) Epidemiology of childhood cancer. IARC Scientific Publication no. 149. International Agency for Research on Cancer, Lyon, France, pp 206–241Google Scholar
  70. 70.
    Littman P, D'Angio GJ (1981) Radiation therapy in the neonate. Am J Pediatr Hematol Oncol 3:279–285PubMedGoogle Scholar
  71. 71.
    Look AT, Hayes FA, Schuster JJ, Douglass EC, Castleberry RP, Bowman LC, Smith EI, Brodeur GM (1991) Clinical relevance of tumour cell ploidy and N-myc amplification in childhood neuroblastoma: a pediatric oncology group study. J Clin Oncol 9:581–591PubMedGoogle Scholar
  72. 72.
    Maruyama K, Ikeda H, Koizumi T, Tsuchida Y, Tanimura M, Nishida H, Takahashi N, Fujimura M, Tokunaga Y (2001) Case-control study of perinatal factors and hepatoblatoma in children with an extremely low birth-weight. Pediatr Int 42:492–498CrossRefGoogle Scholar
  73. 73.
    Mehta NM, Hartnoll G (2001) Congenital CMV with callosal lipoma and agenesis. Pediatr Neurol 24:222–224CrossRefPubMedGoogle Scholar
  74. 74.
    Misdorp W (2002) Tumours in calves: comparative aspects. J Comp Pathol 127:96–105CrossRefPubMedGoogle Scholar
  75. 75.
    Moore SW (1996) Genetic and clinical associations of neonatal tumours. In: Puri P (ed) Neonatal tumours. Springer-Verlag, Berlin Heidelberg New York, pp 11–22Google Scholar
  76. 76.
    Moore SW, Kaschula ROC, Albertyn R, Rode H, Millar AJW, Karabus C (1995) The outcome of solid tumours occurring in the neonatal period. Pediatr Surg Int 10:366–370Google Scholar
  77. 77.
    Mora J, Cheung NK, Kushner BH, LaQuaglia MP, Kramer K, Fazzari M, Heller G, Chen L, Gerald WL (2000) Clinical categories of neuroblastoma are associated with different patterns of loss of heterozygosity on chromosome arm 1p. Mol Diagn 2:37–46PubMedGoogle Scholar
  78. 78.
    Mulvihill JJ (1985) Clinical ecogenetics: cancer in families. N Eng J Med 312:1569–1570Google Scholar
  79. 79.
    Mur N (1992) Neonatal malignant tumours: a retrospective experience. Paper presented at Cancer in the Very Young Conference, St James University Hospital, Leeds, Sept 1990Google Scholar
  80. 80.
    Naumburg E, Bellocco R, Cnattingius S, Jonzon A, Ekbom A (2002) Perinatal exposure to infection and risk of childhood leukaemia. Med Pediatr Oncol 38:391–397CrossRefPubMedGoogle Scholar
  81. 81.
    Ninane J, Gosseye S, Claus D, Otte JB, Cornu G (1981) Cystic partially differentiated nephroblastoma. Helv Paediat Acta 36:377–382PubMedGoogle Scholar
  82. 82.
    Nishi M, Takeda T, Hatae Y, Hanai J, Fujita K, Ichimiya H, Tanaka T (2002) Contribution of HPLC mass screening for neuroblastoma to decrease in mortality. J Exp Clin Cancer Res 21:73–78PubMedGoogle Scholar
  83. 83.
    O'Brien A, Chan HSL, Campbell AN, Smith CR (1986) Malignant neoplasms in the neonate. Lab Invest 54:6PGoogle Scholar
  84. 84.
    Oppedal BR, Storm-Mathisen I, Lie SO, Brandtzaeg P (1988) Prognostic factors in neuroblastoma. Clinical, histopathologic, and immunohistochemical features and DNA ploidy in relation to prognosis. Cancer 62:772–780PubMedGoogle Scholar
  85. 85.
    Pace G, Pantaleone U, D'Orazio A, Agosti R (1989) Un caso di teratoma sacro-coccigeo fetale. Pathologica 81:651–660PubMedGoogle Scholar
  86. 86.
    Parker L (1998) Is infant screening in neuroblastoma saving lives? Med Pediatr Oncol 31:310CrossRefGoogle Scholar
  87. 87.
    Parkes SE, Muir KR, Southern L, Cameron AH, Darbyshire PJ, Stevens MCG (1994) Neonatal tumours: a 30-year population-based study. Med Pediatr Oncol 22:309–317PubMedGoogle Scholar
  88. 88.
    Pinter A, Hock A (1986) Cancer in neonates and infants: National survey of 141 patients. In> Thomasson B, Holschneider AM (eds) 26th Congress of Scandanavian Association of Paediatric surgeons, Stockholm, 22–24 May [Suppl]. Hippokrates Verlag, Stuttgart, pp180–184Google Scholar
  89. 89.
    Plaschkes J (1996) Epidemiology of neonatal tumours. In: P Puri (ed) Neonatal tumours. Springer-Verlag, Heidelberg Berlin New York, pp 11–22Google Scholar
  90. 90.
    Plaschkes J, Dubler M (1989) Neoplasmen beim neugeborenen. Dissertation, Medical Faculty, University of Bern, SwitzerlandGoogle Scholar
  91. 91.
    Potter EL (1991) A historical view: diethylstilbestrol use during pregnancy: a 30-year historical perspective. Pediatr Pathol 11:781–789PubMedGoogle Scholar
  92. 92.
    Powell JE, Esteve J, Mann JR, Parker L, Frappaz D, Michaelis J, Kerbl R, Mutz ID, Stller CA. (1998) Neuroblastoma in Europe: differences in the pattern of disease in the UK. SENSE. Study group for the evaluation of neuroblastoma screening in Europe. Lancet 352:682–687PubMedGoogle Scholar
  93. 93.
    Purtilo DT, Sakamoto K, Barnabei V, Seeley J, Bechtold T, Rogers G, Yetz J, Harada S (1982) Epstein-Barr virus-induced diseases in boys with the X-linked lymphoproliferative syndrome (XLP): update on studies of the registry. Am J Med 73:49–56Google Scholar
  94. 94.
    Rao S, Azmy A, Carachi R (2002) Neonatal tumours: a single centre experience. Pediatr Surg Int 18:306–309CrossRefPubMedGoogle Scholar
  95. 95.
    Rizk T, Nabbout R, Koussa S, Akatcherian C (2000) Congenital brain tumour in a neonate conceived by in vitro fertilization. Childs Nerv Syst 16:501–502PubMedGoogle Scholar
  96. 96.
    Robinson HB Jr, Bolande RP (1985) Case 3. Fetal hepatoblastoma with placental metastases. Pediatr Pathol 4:163–167PubMedGoogle Scholar
  97. 97.
    Ruà S, Olivieri P, Vucusa C (1979) Epatoblastoma in feto alla 36 settimana premorto. Pathologica 71:273–278PubMedGoogle Scholar
  98. 98.
    Sasco AJ, Gendre I, Verbier-Naneix C, Soulier JL, Raffi F, Satgé D, Robert E (1998) Neonatal neuroblastoma and in utero exposure to progestagens. Int J Risks Safety Med 11:121–128Google Scholar
  99. 99.
    Satgé D, van den Berghe H (1996) Aspects of the neoplasms observed in patients with constitutional autosomal trisomy. Cancer Genet Cytogenet 87:63–70CrossRefPubMedGoogle Scholar
  100. 100.
    Satgé D, Philippe E, Ruppe M, Levy JM, Lutz P, Walter P (1988) Les carcinomes néonataux. Revue de la littérature a propos d'un cas. Bull Cancer 75:373–384PubMedGoogle Scholar
  101. 101.
    Satgé D, Sasco AJ, Little J (1998) Antenatal therapeutic drug exposure and fetal/neonatal tumours: review of 89 cases. Paedtr Perinat Epidemiol 12:84–117CrossRefGoogle Scholar
  102. 102.
    Satgé D, Sommelet D, Geneix A, Nishi M, Malet P, Vekemans M (1998) A tumour profile in Down syndrome. Am J Med Genet 78:207–216PubMedGoogle Scholar
  103. 103.
    Sawada T, Matsumura T, Kawakatsu H, Sugimoto T Kuroda H, Hosoi H, Michihata T, Saida T, Hino T, (1991). Long term effects of mass screening for neuroblastoma in infancy Am J Pediatr Hematol Oncol 13:3–7Google Scholar
  104. 104.
    Schilling FH, Spix C, Berthold F, Erttmann R, Fehse N, Hero B, Klein G, Sander J, Schwarz K, Treuner J, Zorn U, Michaelis J (2002) Neuroblastoma screening at 1 year of age. N Engl J Med 346:1047–1053CrossRefPubMedGoogle Scholar
  105. 105.
    Schuz J, Kaatsch P, Kaletsch U, Meinert R, Michaelis J (1999) Association of childhood cancer with factors related to pregnancy and birth. Int J Epidemiol 28:631–639CrossRefPubMedGoogle Scholar
  106. 106.
    Sebire NJ, Ramsay AD, Levitt G, Malone M, Risdon RA (2002) Aberrent immunohistochemical expression in non-rhabdomyosarcoma soft tissue sarcomas in infancy Pediatr Dev Pathol 5:579–586Google Scholar
  107. 107.
    Sherman S, Roizen N (1976) Fetal hydantoin syndrome and neuroblastoma. Lancet 1:517Google Scholar
  108. 108.
    Shibahara H, Mitsuo M, Fujimoto K, Muranaka J, Sawai H, Bessho T, Shigeta M, Koyama K (1999) Prenatal sonographic diagnosis of a fetal renal mesoblastic nephroma occurring after transfer of a cryopreserved embryo. Hum Reprod 14:1324–1327CrossRefPubMedGoogle Scholar
  109. 109.
    Siegel SE, Moran RG (1981) Problems of chemotherapy of cancer in the neonate. Am J Pediatr Hematol Oncol 3:287–296PubMedGoogle Scholar
  110. 110.
    Sikov MR (1989) Tumour development following internal exposures radionuclides during the perinatal period. IARC Sci Publ 96:403–419PubMedGoogle Scholar
  111. 111.
    Skinner MA, Wells SA Jr (1997) Medullary carcinoma of the thyroid and the MEN 2 syndromes. Semin Pediatr Surg 6:134–140PubMedGoogle Scholar
  112. 112.
    Smith AC, Squire JA, Thorner P, Zielenska M, Shuman C, Grant R, Chitayat D, Nishikawa JL, Weksberg R (2001) Association of alveolar rhabdomyosarcoma with Beckwith-Wiedemann syndrome. Pediatr Dev Pathol 4:550–558CrossRefPubMedGoogle Scholar
  113. 113.
    Sutherland GR, Baker E (2000) The clinical significance of fragile sites in humans chromosomes. Clin Genet 58:157–161CrossRefPubMedGoogle Scholar
  114. 114.
    Tafese T, Ertmann R, Favrot M, Berthold F, Kerbl R, Mann J, Parker L, Schilling F, Philip T (1998) Neuroblastoma (NB) screening in Europe: follow-up of high risk cases. Med Pediatr Oncol 31:268CrossRefGoogle Scholar
  115. 115.
    Tang XX, Zhao H, Robinson ME, Cohen B, Cnaan A, London W, Cohn SL, Cheung NK, Brodeur GM, Evans AE, Ikegaki N (2000) Implications of EPHB6, EFNB2, and EFNB3 expressions in human neuroblastoma. Proc Natl Acad Sci USA 97:10936–10941CrossRefPubMedGoogle Scholar
  116. 116.
    Teinturier C, Kalifa C, Hartmann O, Flamant F, Lemerle J (1992) Tumeurs solides malignes néonatales. A propos de 75 cas. Arch Fr Pediatr 49:187–192PubMedGoogle Scholar
  117. 117.
    Tuchman M, Lemieux B, Auray-Blais C, Robison LL, Giguere R, McCann MT, Woods WG (1990) Screening for neuroblastoma at 3 weeks of age: methods and preliminary results from the Quebec neuroblastoma screening project. Pediatrics 86:765–773PubMedGoogle Scholar
  118. 118.
    Tucker T, Friedman JM (2002) Pathogenesis of hereditary tumours: beyond the "two-hit" hypothesis. Clin Genet 62:345–357CrossRefPubMedGoogle Scholar
  119. 119.
    Vogelstein B, Kinzler KW (1993) The multistep nature of cancer. Trends Genet 9:138–141PubMedGoogle Scholar
  120. 120.
    Watanabe N, Kobayashi H, Hirama T, Kikuta A, Koizumi S, Tsuru T, Kaneko Y (2002) Cryptic t(12;15)(p13;q26) producing the ETV6-NTRK3 fusion gene and no loss of IGF2 imprinting in congenital mesoblastic nephroma with trisomy 11: fluorescence in situ hybridization and IGF2 allelic expression analysis. Cancer Genet Cytogenet 136:10–16CrossRefPubMedGoogle Scholar
  121. 121.
    Wei Y, Fabre M, Branchereau S, Gauthier F, Perilongo G, Buendia MA (2000) Activation of beta-catenin in epithelial and mesenchymal hepatoblastomas. Oncogene 19:498–504CrossRefPubMedGoogle Scholar
  122. 122.
    Weinberg AG, Schiller G, Windmiller J (1982) Neonatal leukemoid reaction. An isolated manifestation of mosaic Trisomy 21. Am J Dis Child 136:310–311PubMedGoogle Scholar
  123. 123.
    Weitzman S, Grant R (1997) Neonatal oncology: diagnostic and therapeutic dilemmas. Semin Perinatol 21:102–111PubMedGoogle Scholar
  124. 124.
    Wells HG (1940) Occurrence and significance of congenital malignant neoplasms. Arch Pathol 30:535–601Google Scholar
  125. 125.
    Werb P, Scurry J, Östör A, Fortune D, Attwood H (1992) Survey of congenital tumours in perinatal necropsies. Pathology 24:247–253PubMedGoogle Scholar
  126. 126.
    Woods WG, Lemieux B, Tuchman M (1992) Neuroblastoma represents distinct clinical-biologic entities: a review and perspective from the Quebec Neuroblastoma screening project. Pediatrics 89:114–118PubMedGoogle Scholar
  127. 127.
    Xue H, Horwitz JR, Smith MB, Lally KP, Black CT, Cangir A, Takahashi H, Andrassy RJ (1995) Malignant solid tumours in neonates: a 40-year review. J Pediatr Surg 30:543–545PubMedGoogle Scholar
  128. 128.
    Zhou X, Du X (1998) A clinicopathological analysis of 15 cases with congenital tumours in foetus and newborn (English abstract). Zhonghua Fu Chan Ke Za Zhi 33:290–292PubMedGoogle Scholar

Copyright information

© Springer-Verlag 2003

Authors and Affiliations

  • S. W. Moore
    • 1
    Email author
  • D. Satgé
    • 2
  • A. J. Sasco
    • 3
  • A. Zimmermann
    • 4
  • J. Plaschkes
    • 5
  1. 1.Department of Paediatric SurgeryUniversity of StellenboschCape TownSouth Africa
  2. 2.Laboratoire d'Anatomie Pathologique Centre HospitalierTulleFrance
  3. 3.Epidémiologie Analytique Centre International de Recherche sur le CancerLyonFrance
  4. 4.Department of PathologyUniversity Children's HospitalBerneSwitzerland
  5. 5.Department of Paediatric SurgeryUniversity Children's HospitalBerneSwitzerland

Personalised recommendations